Actinium Pharmaceuticals Stock Price on October 21, 2024
| ATNM Stock | USD 1.45 0.02 1.36% |
Below is the normalized historical share price chart for Actinium Pharmaceuticals extending back to June 02, 2011. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Actinium Pharmaceuticals stands at 1.45, as last reported on the 24th of November, with the highest price reaching 1.49 and the lowest price hitting 1.41 during the day.
If you're considering investing in Actinium Stock, it is important to understand the factors that can impact its price. Actinium Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.11, which signifies that the company had a -0.11% return per unit of risk over the last 3 months. Actinium Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Actinium Pharmaceuticals' Mean Deviation of 3.66, standard deviation of 4.37, and Risk Adjusted Performance of (0.07) to double-check the risk estimate we provide.
At this time, Actinium Pharmaceuticals' Issuance Of Capital Stock is very stable compared to the past year. As of the 24th of November 2024, Stock Based Compensation To Revenue is likely to grow to 49.80, while Common Stock Total Equity is likely to drop about 24 K. . At this time, Actinium Pharmaceuticals' Price To Sales Ratio is very stable compared to the past year. As of the 24th of November 2024, Price Book Value Ratio is likely to grow to 3.90, while Price Earnings To Growth Ratio is likely to drop (0.08). Actinium Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of December 2012 | 200 Day MA 5.4417 | 50 Day MA 1.7434 | Beta 0.146 |
Actinium |
Sharpe Ratio = -0.111
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ATNM |
Estimated Market Risk
| 4.35 actual daily | 38 62% of assets are more volatile |
Expected Return
| -0.48 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Actinium Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Actinium Pharmaceuticals by adding Actinium Pharmaceuticals to a well-diversified portfolio.
Price Book 1.1839 | Enterprise Value Ebitda (3.62) | Price Sales 558.4451 | Shares Float 31 M | Wall Street Target Price 5 |
Related Headline
Adaptimmune Therapeutics Headline on 21st of October 2024
Acquisition by Allen Andrew R of 56868 shares of Adaptimmune... by Allen Andrew R
Filed transaction by Adaptimmune Therapeutics Plc Director. Grant, award or other acquisition pursuant to Rule 16b-3
Actinium Pharmaceuticals Valuation on October 21, 2024
It is possible to determine the worth of Actinium Pharmaceuticals on a given historical date. On October 21, 2024 Actinium was worth 1.82 at the beginning of the trading date compared to the closed value of 1.78. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Actinium Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Actinium Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Actinium Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Actinium Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 1.72 | 1.84 | 1.68 | 1.82 | 363,375 | |
10/21/2024 | 1.82 | 1.84 | 1.77 | 1.78 | 194,417 |
| 1.80 | 1.89 | 1.74 | 1.88 | 276,481 |
| Backtest Actinium Pharmaceuticals | | | Actinium Pharmaceuticals History | | | Actinium Pharmaceuticals Valuation | Previous | Next |
Actinium Pharmaceuticals Trading Date Momentum on October 21, 2024
| On October 22 2024 Actinium Pharmaceuticals was traded for 1.88 at the closing time. The top price for the day was 1.89 and the lowest listed price was 1.74 . The trading volume for the day was 276.5 K. The trading history from October 22, 2024 was a factor to the next trading day price boost. The overall trading delta against the next closing price was 5.62% . The overall trading delta against the current closing price is 1.12% . |
Actinium Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Actinium Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Actinium Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Actinium financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Actinium Pharmaceuticals Stock history
Actinium Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Actinium is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Actinium Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Actinium Pharmaceuticals stock prices may prove useful in developing a viable investing in Actinium Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 26.6 M | 27.9 M | |
| Net Loss | -29.7 M | -31.2 M |
Actinium Pharmaceuticals Quarterly Net Working Capital |
|
Actinium Pharmaceuticals Stock Technical Analysis
Actinium Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Actinium Pharmaceuticals Period Price Range
Low | November 24, 2024
| High |
0.00 | 0.00 |
Actinium Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NYSE MKT Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Actinium Pharmaceuticals November 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Actinium Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Actinium Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Actinium Pharmaceuticals stock market strength indicators, traders can identify Actinium Pharmaceuticals entry and exit signals to maximize returns
Actinium Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Actinium Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Actinium Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Actinium to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.69) | |||
| Total Risk Alpha | (1.12) | |||
| Treynor Ratio | (0.20) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Actinium Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Actinium Stock, please use our How to Invest in Actinium Pharmaceuticals guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Actinium Pharmaceuticals. If investors know Actinium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Actinium Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.39) | Revenue Per Share 0.003 | Quarterly Revenue Growth (1.00) | Return On Assets (0.31) | Return On Equity (0.88) |
The market value of Actinium Pharmaceuticals is measured differently than its book value, which is the value of Actinium that is recorded on the company's balance sheet. Investors also form their own opinion of Actinium Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Actinium Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Actinium Pharmaceuticals' market value can be influenced by many factors that don't directly affect Actinium Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Actinium Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Actinium Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Actinium Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.